We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug & Device Products
FDAnews Books Library
Events
Form 483s Database
Publications
Webinar Training Pass
eCFR and Guidances
Books
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Anh Lac
Anh Lac
Products
PRODUCTS
Actelion Pharmaceuticals U.S., Inc.
Anh Lac
Price:
$117.00
View
Park Infusioncare LP dba Preferred Homecare
Anh Lac
Price:
$117.00
View
3D Imaging Drug Design and Development
Anh Lac
and
Shawn E. Larson
Price:
$117.00
View
Yancheng Youhua Pharmaceutical & Chemical Technology Co.
Guang Gao
and
Anh Lac
Price:
$117.00
View
Shandong Luwei Pharmaceutical Co., Ltd.
Anh Lac
Price:
$117.00
View
Novacyl Wuxi Pharmaceutical Co., Ltd.
Peter E. Baker
and
Anh Lac
Price:
$117.00
View
Guardian Pharmacy Services
Patrice Hall
and
Anh Lac
Price:
$117.00
View
Jajco, Inc. dba Anchor Drugs Pharmacy
Anh Lac
,
Henry K. Lau
, and
Stephanie A. Slater
Price:
$117.00
View
BioZone Laboratories, Inc.
Anh Lac
Price:
$117.00
View
GS Cosmeceutical USA, Inc.
Anh Lac
Price:
$117.00
View
View All Products by Anh Lac
Upcoming Events
28
Jun
Effective Root Cause Analysis and CAPA Investigations for the Life Sciences
13
Jul
FDA Ad and Promo Enforcement Trends: Past, Present and Future
28
Jul
EU-MDR’s Growing Pains: Are You Current with the Latest Developments?
28
Jul
Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does
02
Aug
Medical Device Cybersecurity: Understand the Latest Developments
03
Aug
Pharmaceutical Process Validation: Best Practices for Success
Featured Products
FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485
Selecting and Implementing Electronic Document Management Systems in the EU
Featured Stories
Okami Medical’s LOBO-7 and LOBO-9 Vascular Occluders Cleared
FDA Puts Clinical Hold on Astellas Late-Onset Pompe Disease Clinical Trial
FDA Provides Update on GE Healthcare’s Recall of Its Carescape R860 Ventilators
Gilead Resubmits NDA for Lenacapavir Following Complete Response Letter
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
